‰@’·‚ÌŒo—ð
|
Ž–¼ |
•ЊÝ@’B•v |
|
”N—î |
40 |
|
|
|
|
—ª—ð |
|
|
º˜a59”N |
‘åã•{—§‚’ÂZ‘²‹Æ |
|
º˜a60”N |
‹ž“s•{—§ˆã‰È‘åŠw“üŠw |
|
•½¬3”N |
‹ž“s•{—§ˆã‰È‘åŠw‘²‹ÆA‘æŽO“à‰È“ü‹Ç |
|
•½¬4”N |
’©“ú‘åŠw•‘®‘ºã‹L”O•a‰@Á‰»Ší“à‰È |
|
•½¬6”N |
‹ž“s•{—§ˆã‰È‘åŠw@‘åŠw‰@i“à‰ÈŠw‚Rj |
|
•½¬10”N |
•Њ݈ã‰@ŠJÝ |
|
•½¬11”N |
ˆãŠw”ŽŽm†Žæ“¾iTelomere and Telomerase activity in Hepatocellular carcinoma) |
|
|
|
|
ê–å—̈æ |
“à‰È‘S”ÊAŠÌ‘ŸAÁ‰»ŠÇ |
|
”F’èˆãEê–åˆã |
“ú–{“à‰ÈŠw‰ï”F’èê–åˆãA“ú–{ŠÌ‘ŸŠw‰ï@ŠÌ‘Ÿê–åˆãA“ú–{Á‰»Ší•aŠw‰ï@Á‰»Ší•aê–åˆãA“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï@“àŽ‹‹¾ê–åˆã |